ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Cancer
Fallopian Tube Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Ovarian Cancer trials near Roma, Lazio, ITA:

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) (DO-01)

in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...

Enrolling
Ovarian Cancer
Drug: Trastuzumab Deruxtecan
Drug: Bevacizumab

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Roma, Italy and 207 other locations

followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...

Active, not recruiting
Advanced Ovarian Cancer
Drug: Bevacizumab
Drug: Durvalumab placebo

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 213 other locations

of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...

Active, not recruiting
Relapsed Ovarian Cancer
Following Complete or Partial Response to Platinum Based Chemotherapy
Drug: Placebo to match olaparib 300mg
Drug: Olaparib 300mg tablets

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 126 other locations

choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expressio...

Enrolling
Ovarian Cancer
Drug: Azenosertib
Drug: Investigator's choice of Chemotherapy

Phase 3

K-Group Beta

Rome, Italy and 58 other locations

Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....

Active, not recruiting
Advanced Ovarian Cancer
FIGO Stage III-IV
Drug: Olaparib 300mg tablets

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 176 other locations

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...

Enrolling
Low Grade Serous Ovarian Cancer
Drug: Defactinib
Drug: Letrozole

Phase 3

Verastem

Roma, Italy and 106 other locations

(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...

Enrolling
Epithelial Ovarian Cancer
Drug: Topotecan
Drug: Mirvetuximab Soravtansine (MIRV)

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 298 other locations

A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....

Enrolling
Epithelial Ovarian Cancer
Endometrioid Ovarian Cancer
Drug: Pegfilgrastim (drug)
Drug: TORL-1-23

Phase 2

TORL Biotherapeutics

Rome, Rome, Italy and 65 other locations

This is a single arm phase II, multicenter study evaluating Pembrolizumab in recurrent platinum resistant CPS score \>1 positive ovarian, Fa...

Enrolling
Fallopian Tube Cancer
Ovarian Cancer
Drug: Pembrolizumab

Phase 2

Institute of Hospitalization and Scientific Care (IRCCS)

Rome, Italy

of ubamatamab can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study wil...

Enrolling
Endometrial Cancer
Recurrent Primary Peritoneal Cancer
Drug: Sarilumab
Drug: Ubamatamab

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Rome, Lazio, Italy and 54 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems